IMS Health Chooses Cloudera Enterprise to Support Big Data Factory for Life Sciences and Healthcare
05 Julio 2016 - 8:00AM
Business Wire
Open Source Technologies to Drive
Next-Generation Data Processing and More Comprehensive Insights,
Faster
IMS Health (NYSE:IMS) today announced that it has selected
Cloudera Enterprise to support its Big Data Factory, a cloud-based
platform that transforms data into intelligence for life sciences
and healthcare clients as they navigate dynamic markets, drive
operational excellence and demonstrate the value of medicines. The
collaboration with Cloudera—a leader in enterprise analytics data
management powered by Apache Hadoop and the latest open source
technologies—will accelerate and enhance data acquisition,
processing and warehousing in the factory.
“As IMS Health continues to innovate with Big Data, Cloudera
will advance our efforts to build and provision breakthrough data
processing and data warehousing solutions,” said Karl Guenault,
chief information officer and vice president of Operations, IMS
Health. “We’re excited to apply Hadoop and other open source
technologies for integrating, processing and interpreting more
extensive and granular data—helping our customers drive healthcare
performance.”
The combined solution will support:
- Next-generation data processing.
Cloudera’s latest open source technology platforms support machine
learning—which uses cognitive systems to automate quality control,
data bridging and modeling, and other repetitive tasks—to drive
evidence-based decisions for clients. Using the Hadoop cluster
technology, IMS Health can extract, store and analyze vast
quantities of unstructured data for generating new, more
comprehensive insights for customers.
- Accelerated time to insight. The
IMS Health Big Data Factory will harness Hadoop’s parallel
processing technology to streamline data acquisition and
management, delivering powerful insights with higher
efficiency.
- Scalable data management. The
Hadoop distributed file system (HDFS) eliminates data transfer
bottlenecks, storage capacity delays and time spent adding new
servers to augment traditional data clusters—enabling IMS Health to
improve the speed and scalability of Big Data management.
“The insight that IMS Health will gain through the platform can
ultimately be measured in better patient outcomes, and Cloudera is
thrilled to work with them on this endeavor,” said Shawn Dolley,
Cloudera industry leader for Health and Life Sciences. “As the
leading provider of open source Hadoop solutions, Cloudera and IMS
Health are uniquely positioned to support the growing needs of
healthcare organizations looking to optimize their data utilization
and provide better care.”
About Cloudera
Cloudera delivers the modern data management and analytics
platform built on Apache Hadoop and the latest open source
technologies. The world’s leading organizations trust Cloudera to
help solve their most challenging business problems with Cloudera
Enterprise, the fastest, easiest and most secure data platform
available for the modern world. Our customers efficiently capture,
store, process and analyze vast amounts of data, empowering them to
use advanced analytics to drive business decisions quickly,
flexibly and at lower cost than has been possible before. To ensure
our customers are successful, we offer comprehensive support,
training and professional services. Learn more at cloudera.com.
About IMS Health
IMS Health is a leading global information and technology
services company providing clients in the healthcare industry with
end-to-end solutions to measure and improve their performance. Our
7,000 services experts connect configurable SaaS applications to
15+ petabytes of complex healthcare data in the IMS One™ cloud
platform, delivering unique insights into diseases, treatments,
costs and outcomes. The company’s 15,000 employees blend global
consistency and local market knowledge across 100 countries to help
clients run their operations more efficiently. Customers include
pharmaceutical, consumer health and medical device manufacturers
and distributors, providers, payers, government agencies,
policymakers, researchers and the financial community.
As a global leader in protecting individual patient privacy, IMS
Health uses anonymous healthcare data to deliver critical,
real-world disease and treatment insights. These insights help
biotech and pharmaceutical companies, medical researchers,
government agencies, payers and other healthcare stakeholders to
identify unmet treatment needs and understand the effectiveness and
value of pharmaceutical products in improving overall health
outcomes. Additional information is available at
www.imshealth.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160705005045/en/
IMS HealthTor Constantino,
+1-484-567-6732tconstantino@us.imshealth.com
IMS HEALTH HOLDINGS, INC. (NYSE:IMS)
Gráfica de Acción Histórica
De Dic 2024 a Ene 2025
IMS HEALTH HOLDINGS, INC. (NYSE:IMS)
Gráfica de Acción Histórica
De Ene 2024 a Ene 2025